Cargando…
The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson’s Disease
Trimetazidine is contraindicated in movement disorders, however, a not negligible part of trimetazidine users is still patients with Parkinson’s disease (PD). The present study aimed to objectively determine the impact of trimetazidine on the severity of symptoms and the health-related quality of li...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7308301/ https://www.ncbi.nlm.nih.gov/pubmed/32572075 http://dx.doi.org/10.1038/s41598-020-66692-5 |